(Q40866416)
Statements
1 reference
A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants (English)
1 reference
Lucas KG
1 reference
Sun Q
1 reference
Burton RL
1 reference
Tilden A
1 reference
Vaughan WP
1 reference
Carabasi M
1 reference
Salzman D
1 reference
Ship A
1 reference
1 July 2000
1 reference
1 reference
11
1 reference
10
1 reference
1453-1463
1 reference
Identifiers
1 reference
1 reference